PROLONGED THERAPY OF HEPATITIS DELTA FOR 96 WEEKS WITH PEGYLATED-INTERFERON-?-2a PLUS TENOFOVIR OR PLACEBO DOES NOT PREVENT HDV RNA RELAPSE AFTER TREATMENT: THE HIDIT-2 STUDY

dc.contributor.authorWedemeyer, H.
dc.contributor.authorYurdaydin, C.
dc.contributor.authorErnst, S.
dc.contributor.authorCaruntu, F. A.
dc.contributor.authorCurescu, M. G.
dc.contributor.authorYalcin, K.
dc.contributor.authorAkarca, U. S.
dc.date.accessioned2024-04-24T16:18:49Z
dc.date.available2024-04-24T16:18:49Z
dc.date.issued2014
dc.departmentDicle Üniversitesien_US
dc.description49th Annual International Liver Congress of the European-Association-for-the-Study-of-the-Liver -- APR 09-13, 2014 -- London, ENGLANDen_US
dc.description.abstract[Abstract Not Available]en_US
dc.description.sponsorshipEuropean Assoc Study Liveren_US
dc.identifier.doi10.1016/S0168-8278(14)60006-4
dc.identifier.endpageS3en_US
dc.identifier.issn0168-8278
dc.identifier.issn1600-0641
dc.identifier.issue1en_US
dc.identifier.startpageS2en_US
dc.identifier.urihttps://doi.org/10.1016/S0168-8278(14)60006-4
dc.identifier.urihttps://hdl.handle.net/11468/16292
dc.identifier.volume60en_US
dc.identifier.wosWOS:000361961700005
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoenen_US
dc.publisherElsevier Science Bven_US
dc.relation.ispartofJournal of Hepatology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keyword]en_US
dc.titlePROLONGED THERAPY OF HEPATITIS DELTA FOR 96 WEEKS WITH PEGYLATED-INTERFERON-?-2a PLUS TENOFOVIR OR PLACEBO DOES NOT PREVENT HDV RNA RELAPSE AFTER TREATMENT: THE HIDIT-2 STUDYen_US
dc.titlePROLONGED THERAPY OF HEPATITIS DELTA FOR 96 WEEKS WITH PEGYLATED-INTERFERON-?-2a PLUS TENOFOVIR OR PLACEBO DOES NOT PREVENT HDV RNA RELAPSE AFTER TREATMENT: THE HIDIT-2 STUDY
dc.typeConference Objecten_US

Dosyalar